Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA approves clinical trial wearables

Greenlights Camntech's MotionWatch and Pro-Diary medical devices

Camntech Pro-DiaryUS regulators have approved two new wristwatch-like devices for use in clinical trials.

Cambridge, UK-based firm CamNtech's MotionWatch and Pro-Diary medical devices both use 'accelerometer' motion sensors to document physical movement.

The Pro-Diary (pictured) also has a built-in score pad to capture patient reported outcomes and which can be used instead of, or in addition to, traditional written patient diary in conjunction with activity monitoring.

They join CamNtech's existing Actilheart and Actiwave devices on the market and have been cleared by the FDA “to assess activity in any instance where quantifiable analysis of physical motion is desired”.

Such uses could include monitoring limb or body movements during daily living and sleep.

A number of wearable devices have hit the consumer market in the last year or so, including Fitbit and Nike's FuelBand but, as MobiHealthNews notes, the only consumer device to win FDA approval so far has been the BodyMedia CORE Armband.

14th February 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics